Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortex

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 6, 2008, Pages 1516-1520

  Egashira, Nobuaki ^a,b   Iwasaki, Katsunori ^a   Ishibashi, Ayumi ^a   Hayakawa, Kazuhide ^a   Okuno, Ryoko ^a   Abe, Moe ^a   Uchida, Naoki ^c   Mishima, Kenichi ^a   Takasaki, Kotaro ^a   Nishimura, Ryoji ^c   Oishi, Ryozo ^b   Fujiwara, Michihiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

^c FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 HT2A receptor; Behavioral and psychological symptoms of dementia; DOI; Head twitch response; Yokukansan

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; HERBACEOUS AGENT; SEROTONIN 2A RECEPTOR; YOKUKANSAN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; HEAD TWITCH; MALE; MOUSE; NEUROPSYCHIATRY; NONHUMAN; PREFRONTAL CORTEX; PROTEIN EXPRESSION; PSYCHOPHARMACOLOGY; TRADITIONAL MEDICINE;

AMPHETAMINES; ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; CATALEPSY; DEMENTIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; HYPOTHALAMUS; MALE; MICE; MICROINJECTIONS; MOTOR ACTIVITY; POSTURAL BALANCE; PREFRONTAL CORTEX; PSYCHOMOTOR PERFORMANCE; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN RECEPTOR AGONISTS;

EID: 47749127667     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.05.010     Document Type: Article

References (26)

1. Barnes N., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
2. 2A receptor antagonist. Eur J Pharmacol 473 (2003) 229-230
3. Casey D. Tardive dyskinesia and atypical antipsychotic drugs. Schizophr Res 35 (1999) S61-S66
4. Corne S., and Pickering R. A possible correlation between drug-induced hallucinations in man and a behavioral response in mice. Psychopharmacologia 11 (1967) 65-78
5. Corne S., Pickering R., and Warner B. A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. Br J Pharmacol Chemother 20 (1963) 106-120
6. 2 receptors?. Pharmacol Biochem Behav 36 (1990) 901-906
7. 2A receptor-mediated behavior in the rabbit. J Pharmacol Exp Ther 323 (2007) 327-335
8. Egashira N., Mishima K., Uchida T., Hasebe N., Nagai H., Mizuki A., et al. Anandamide inhibits the DOI-induced head-twitch response in mice. Psychopharmacology 171 (2004) 382-389
9. Egashira N., Tanoue A., Higashihara F., Mishima K., Fukue Y., Takano Y., et al. V1a receptor knockout mice exhibit impairment of spatial memory in an eight-arm radial maze. Neurosci Lett 356 (2004) 195-198
10. Finkel S. Behavioral and psychologic symptoms of dementia. Clin Geriatr Med 19 (2003) 799-824
11. Garcia-Alloza M., Gil-Bea F., Diez-Ariza M., Chen C., Francis P., Lasheras B., et al. Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease. Neuropsychologia 43 (2005) 442-449
12. 2 agonists or antagonists?. Neuropsychopharmacology 3 (1990) 509-517
13. 2A receptor-mediated signaling pathways to affect behavior. Neuron 53 (2007) 439-452
14. Iwasaki K., Maruyama M., Tomita N., Furukawa K., Nemoto M., Fujiwara H., et al. Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies. J Clin Psychiatry 66 (2005) 1612-1613
15. Iwasaki K., Satoh-Nakagawa T., Maruyama M., Monma Y., Nemoto M., Tomita N., et al. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. J Clin Psychiatry 66 (2005) 248-252
16. 2A antagonist with a favorable CNS safety profile. J Pharmacol Exp Ther 277 (1996) 968-981
17. Koshikawa N., Imai T., Takahashi I., Yamauchi M., Sawada S., and Kansaku A. Effects of Hochu-ekki-to, Yoku-kan-san and Saiko-ka-ryukotsu-borei-to on behavioral despair and acetic acid-induced writhing in mice. Methods Find Exp Clin Pharmacol 20 (1998) 47-51
18. Lanctôt K., Herrmann N., and Mazzotta P. Role of serotonin in the behavioral and psychological symptoms of dementia. J Neuropsychiatry Clin Neurosci 13 (2001) 5-21
19. 2 receptors. Psychopharmacology 112 (1993) S40-54
20. 2C receptor agonists: pharmacological characteristics and therapeutic potential. J Pharmacol Exp Ther 286 (1998) 913-924
21. 9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice. Pharmacol Biochem Behav 84 (2006) 330-336
22. 2C polymorphisms in behavioural and psychological symptoms of Alzheimer's disease. Neurobiol Aging 29 (2008) 341-347
23. Rubin E., Drevets W., and Burke W. The nature of psychotic symptoms in senile dementia of the Alzheimer type. J Geriatr Psychiatry Neurol 1 (1988) 16-20
24. Shinno H., Utani E., Okazaki S., Kawamukai T., Yasuda H., Inagaki T., et al. Successful treatment with Yi-Gan San for psychosis and sleep disturbance in a patient with dementia with Lewy bodies. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 1543-1555
25. Walsh J., Welch H., and Larson E. Survival of outpatients with Alzheimer-type dementia. Ann Intern Med 113 (1990) 429-434
26. 2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J Pharmacol Exp Ther 282 (1997) 699-706